CYRX

Cryoport, Inc.

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.

Cryoport, Inc. (CYRX) is rated C+ (2.5/5) on Deltasharpe Prism, scored against Industrials sector peers. Its strongest pillar is Momentum (A); its weakest is Value (D-). The rating has held at C+ for 10 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.5 / 5.0
C+
Value
D-
Factor Score 1.0 / 5.0
Growth
C
Factor Score 2.3 / 5.0
Profitability
C+
Factor Score 2.7 / 5.0
Momentum
A
Factor Score 4.4 / 5.0
Revisions
C
Factor Score 2.3 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -38.8
EV / EBITDA 1.4K
Rev Growth YoY 13.5%
Gross Margin 46.9%
Price Return 3M 40.1%
Price Return 12M 147.5%
Catalyst Signal 0.00
Market Cap $1.1B
TTM Revenue $192.4M
Price / Sales 5.5
ROE -7.4%

Historical Factor Score Progression

Held C+ for 10 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 D- (1.0) C (2.3) C+ (2.7) A (4.4) C (2.3) C+ (2.5)
2026-11-04 C (2.4) C- (1.9) C+ (2.7) A- (4.1) C (2.3) C+ (2.7)
2026-10-28 C (2.4) C- (1.9) C+ (2.6) A (4.4) C (2.2) C+ (2.7)
2026-10-21 C (2.4) C- (1.9) C+ (2.6) A- (4.0) C (2.2) C+ (2.6)
2026-10-14 C (2.5) C- (1.9) C+ (2.6) B+ (3.7) C (2.2) C+ (2.6)
Page 1 of 6